ES2133738T3 - Metodo para cuantificar lbp en fluidos corporales. - Google Patents

Metodo para cuantificar lbp en fluidos corporales.

Info

Publication number
ES2133738T3
ES2133738T3 ES95909325T ES95909325T ES2133738T3 ES 2133738 T3 ES2133738 T3 ES 2133738T3 ES 95909325 T ES95909325 T ES 95909325T ES 95909325 T ES95909325 T ES 95909325T ES 2133738 T3 ES2133738 T3 ES 2133738T3
Authority
ES
Spain
Prior art keywords
body fluids
lbp
quantifying
quantifying lbp
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95909325T
Other languages
English (en)
Inventor
Mark Leslie White
Stephen Fitzhugh Carroll
Jeremy Kam-Kuen Ma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xoma Corp
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Application granted granted Critical
Publication of ES2133738T3 publication Critical patent/ES2133738T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UN METODO PARA CUANTIFICAR LA PRESENCIA DE LBP EXTRACELULAR EN FLUIDOS CORPORALES INCLUYENDO LA SANGRE EN UN SUJETO, QUE IMPLICA LLEVAR A CABO UN INMUNOENSAYO LBP DEL PLASMA OBTENIDO DE DICHO SUJETO.
ES95909325T 1994-01-24 1995-01-24 Metodo para cuantificar lbp en fluidos corporales. Expired - Lifetime ES2133738T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/186,811 US5484705A (en) 1994-01-24 1994-01-24 Method for quantifying lipopolysaccharide binding protein

Publications (1)

Publication Number Publication Date
ES2133738T3 true ES2133738T3 (es) 1999-09-16

Family

ID=22686373

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95909325T Expired - Lifetime ES2133738T3 (es) 1994-01-24 1995-01-24 Metodo para cuantificar lbp en fluidos corporales.

Country Status (13)

Country Link
US (3) US5484705A (es)
EP (1) EP0741870B1 (es)
JP (1) JP3554331B2 (es)
CN (1) CN1132013C (es)
AT (1) ATE182216T1 (es)
AU (1) AU701710B2 (es)
DE (1) DE69510772T2 (es)
DK (1) DK0741870T3 (es)
ES (1) ES2133738T3 (es)
GR (1) GR3031303T3 (es)
HK (1) HK1015174A1 (es)
MX (1) MX9602688A (es)
WO (1) WO1995020163A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5891618A (en) * 1994-01-24 1999-04-06 Xoma Corporation Method for quantifying LBP in body fluids
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein
US5932536A (en) * 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
EP0839156A1 (en) * 1995-07-20 1998-05-06 Xoma Corporation Anti-fungal peptides
NZ332720A (en) * 1996-05-10 2000-07-28 Xoma Corp Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
AU736096B2 (en) * 1996-05-23 2001-07-26 Xoma Corporation Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma
US5888973A (en) * 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US5990082A (en) * 1997-10-22 1999-11-23 Xoma Corporation Uses of lipopolysaccharide binding protein
US6013631A (en) 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
US7465555B2 (en) * 2002-04-02 2008-12-16 Becton, Dickinson And Company Early detection of sepsis
CA2505785A1 (en) * 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
BR0316231A (pt) * 2002-11-12 2005-10-04 Becton Dickinson Co Métodos para determinar o estado de sepsia para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo e para isolar um biomarcador, perfil biomarcador r kit
WO2004044555A2 (en) * 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
US20060157647A1 (en) * 2005-01-18 2006-07-20 Becton, Dickinson And Company Multidimensional liquid chromatography/spectrometry
AU2006236588A1 (en) 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
ATE549129T1 (de) * 2007-04-26 2012-03-15 Adept Technology Inc Vakuumgreifvorrichtung
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
US7846678B2 (en) * 2008-08-18 2010-12-07 BioDtech, Inc. Enhancing endotoxin detection
JP5674664B2 (ja) * 2008-09-04 2015-02-25 ベックマン コールター， インコーポレイテッド パンキナーゼ活性化およびシグナリング経路の評価
CN104407156B (zh) * 2014-12-05 2016-03-16 重庆中元生物技术有限公司 检测多糖结合蛋白(lbp)的胶乳增强免疫比浊试剂盒及其制备方法
CN109507323A (zh) * 2018-12-07 2019-03-22 上海浩港生物技术有限公司 一种用质谱仪检测人类血液中lbp含量的试剂盒
CN109507127A (zh) * 2018-12-07 2019-03-22 上海浩港生物技术有限公司 一种用于检测人类血液中lbp含量的试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310879A (en) * 1985-04-30 1994-05-10 The Scripps Research Institute Antibodies which immunoreact with lapine lipopolysaccharide binding protein (LBP)
US5245013A (en) * 1985-04-30 1993-09-14 Richard Ulevitch Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides
WO1986006279A1 (en) * 1985-04-30 1986-11-06 Scripps Clinic And Research Foundation Acute phase protein modulating endotoxic activity of lipopolysaccharides, compositions and methods
DE69032662T2 (de) * 1989-08-01 1999-03-11 Scripps Research Inst Verfahren und zusammensetzungen zur verbesserung der symptome von sepsis
JPH07502642A (ja) * 1991-09-26 1995-03-23 インサイト　ファーマシューティカルズ，インコーポレイテッド 新規な形態のリポ糖結合性タンパク質（ｌｂｐ）
AU6522794A (en) * 1993-03-22 1994-10-11 Incyte Pharmaceuticals, Inc. Use of bactericidal/permeability increasing protein and lipopolysaccharide binding protein levels and ratios thereof in diagnosis
CA2161971A1 (en) * 1993-04-30 1994-11-10 Randal W. Scott Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
AU7175694A (en) * 1993-06-17 1995-01-17 Xoma Corporation Lipopolysaccharide binding protein derivatives
AU7330994A (en) * 1993-07-14 1995-02-13 Xoma Corporation Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein

Also Published As

Publication number Publication date
GR3031303T3 (en) 1999-12-31
HK1015174A1 (en) 1999-10-08
AU1732195A (en) 1995-08-08
EP0741870B1 (en) 1999-07-14
DK0741870T3 (da) 1999-12-13
AU701710B2 (en) 1999-02-04
US6274328B1 (en) 2001-08-14
EP0741870A1 (en) 1996-11-13
JPH09508465A (ja) 1997-08-26
US5804367A (en) 1998-09-08
MX9602688A (es) 1997-05-31
CN1139485A (zh) 1997-01-01
DE69510772T2 (de) 1999-11-11
US5484705A (en) 1996-01-16
ATE182216T1 (de) 1999-07-15
WO1995020163A1 (en) 1995-07-27
JP3554331B2 (ja) 2004-08-18
CN1132013C (zh) 2003-12-24
DE69510772D1 (de) 1999-08-19

Similar Documents

Publication Publication Date Title
ES2133738T3 (es) Metodo para cuantificar lbp en fluidos corporales.
NO20001238L (no) Monoklonalt antistoff som induserer apoptose
EP0987550A3 (en) Analytical test device and method of use
DE69728585D1 (de) Mittel gegen Juckreiz
ES2177810T3 (es) Lamina recubierta de aerogel.
EA199800857A1 (ru) Композиция для снятия боли и способ снятия боли
DE69626683T2 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
ATE279643T1 (de) Ölwanne mit integrierter ölfiltereinheit
WO2000018922A8 (en) Human carbohydrate-associated proteins
ES2126151T3 (es) Metodo para cuantificar bpi extracelular en fluidos corporales.
ES2186247T3 (es) Metodo de configurar un instrumento portatil.
WO2000012703A3 (en) Protein transport-associated molecules
WO2001098354A3 (en) Human receptors
WO2000017355A3 (en) Human cytoskeleton associated proteins
WO1998055509A3 (en) Two human dnaj-like proteins
MX9400799A (es) Dispositivo para la recoleccion de sangre.
DE68909050D1 (de) Abnutzungsdetektionsvorrichtung für Schmieröl.
EA199700449A1 (ru) Способ предотвращения остеопороза
CA2181815A1 (en) Method for quantifying lbp in body fluids
SE9503289L (sv) Metod för bestämning av axialkraften i en långsträckt kropp
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
ES2174150T3 (es) Procedimiento para la obtencion de 4-hidroxianilinas.
WO2000004135A3 (en) Human scad-related molecules, scrm-1 and scrm-2
WO1998057986A3 (en) Human preprotachykinin b
WO2000024911A3 (en) Human phospholipases

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 741870

Country of ref document: ES